Driehaus Capital Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,270,931
| Closed | -$37.5M | – | 487 |
|
|
2025
Q1 | $37.5M | Buy |
1,270,931
+42,873
| +3% | +$1.27M | 0.36% | 87 |
|
|
2024
Q4 | $35.7M | Buy |
1,228,058
+356,114
| +41% | +$10.4M | 0.29% | 112 |
|
|
2024
Q3 | $40M | Buy |
+871,944
| New | +$40M | 0.34% | 98 |
|
|
2023
Q2 | – | Sell |
-313,542
| Closed | -$4.81M | – | 459 |
|
|
2023
Q1 | $4.81M | Sell |
313,542
-37,703
| -11% | -$579K | 0.07% | 294 |
|
|
2022
Q4 | $7.79M | Buy |
+351,245
| New | +$7.79M | 0.12% | 237 |
|